The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Development of potent monoclonal antibody auristatin conjugates for cancer therapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Untangling the ErbB signalling network
Yarden, Y., & Sliwkowski, M. X. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35052073 · Cited by 6,974
Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia.
Bross, P. F., Beitz, J. G., Chen, G., Chen, X., Duffy, E. J., Kieffer, L. V., Roy, S., Sridhara, R. N., Rahman, A., Williams, G., et al. (2001) · PubMed · Cited by 855
Improving the efficacy of antibody-based cancer therapies
Carter, P. (2001) · Nature Reviews Cancer · doi:10.1038/35101072 · Cited by 833
THE MAMMALIAN CARBOXYLESTERASES: From Molecules to Functions
Satoh, T., & Hosokawa, M. (1998) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.257 · Cited by 758
Hamann, P. R., Hinman, L. M., Hollander, I., Beyer, C. F., Lindh, D., Holcomb, R., Hallett, W., Tsou, H.-R., Upeslacis, J., Shochat, D., et al. (2002) · Bioconjugate Chemistry · doi:10.1021/bc010021y · Cited by 594
Unraveling the role of proteases in cancer
Koblinski, J. E., Ahram, M., & Sloane, B. F. (2000) · Clinica Chimica Acta · doi:10.1016/s0009-8981(99)00224-7 · Cited by 580
Physiological barriers to delivery of monoclonal antibodies and other macromolecules in tumors.
Jain, R. K. (1990) · PubMed · Cited by 574
Cure of Xenografted Human Carcinomas by BR96-Doxorubicin Immunoconjugates
Trail, P. A., Willner, D., Lasch, S. J., Henderson, A. J., Hofstead, S., Casazza, A. M., Firestone, R. A., Hellström, I., & Hellström, K. E. (1993) · Science · doi:10.1126/science.8327892 · Cited by 556
Dubowchik, G. M., Firestone, R. A., Padilla, L., Willner, D., Hofstead, S. J., Mosure, K., Knipe, J. O., Lasch, S. J., & Trail, P. A. (2002) · Bioconjugate Chemistry · doi:10.1021/bc025536j · Cited by 555
A novel connector linkage applicable in prodrug design
Carl, P. L., Chakravarty, P. K., & Katzenellenbogen, J. A. (1981) · Journal of Medicinal Chemistry · doi:10.1021/jm00137a001 · Cited by 351
Receptor-mediated and enzyme-dependent targeting of cytotoxic anticancer drugs
Dubowchik, G. M., & Walker, M. A. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00018-2 · Cited by 277
Trouet, A., Masquelier, M., Baurain, R., & Deprez-De Campeneere, D. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.2.626 · Cited by 233
Hamann, P. R., Hinman, L. M., Beyer, C. F., Lindh, D., Upeslacis, J., Flowers, D. A., & Bernstein, I. (2002) · Bioconjugate Chemistry · doi:10.1021/bc0100206 · Cited by 230
Wahl, A. F., Klussman, K., Thompson, J. D., Chen, J. H., Francisco, L. V., Risdon, G., Chace, D. F., Siegall, C. B., & Francisco, J. A. (2002) · PubMed · Cited by 226
Self-citationSaleh, M. N., Sugarman, S., Murray, J., Ostroff, J. B., Healey, D., Jones, D., Daniel, C. R., LeBherz, D., Brewer, H., Onetto, N., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.11.2282 · Cited by 196
Eradication of large colon tumor xenografts by targeted delivery of maytansinoids.
Liu, C., Tadayoni, B. M., Bourret, L. A., Mattocks, K. M., Derr, S. M., Widdison, W. C., Kedersha, N. L., Ariniello, P. D., Goldmacher, V. S., Lambert, J. M., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8618 · Cited by 196
Vaishampayan, U. N., Glodé, M., Du, W., Kraft, A. S., Hudes, G. R., Wright, J. D., & Hussain, M. (2000) · PubMed · Cited by 160
King, D., Dubowchik, G. M., Mastalerz, H. A., Willner, D., Hofstead, S. J., Firestone, R. A., Lasch, S. J., & Trail, P. A. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020149g · Cited by 135
de Groot, F. M. H., Damen, E. W. P., & Scheeren, H. W. (2001) · Current Medicinal Chemistry · doi:10.2174/0929867013372634 · Cited by 129
CHARI, R. V. J., Jackel, K. A., Bourret, L. A., Derr, S. M., Tadayoni, B. M., Mattocks, K. M., Shah, S., Liu, C., Blättler, W. A., & Goldmacher, V. S. (1995) · PubMed · Cited by 119
Tumor-Specific Novel Taxoid−Monoclonal Antibody Conjugates
Ojima, I., Geng, X., Wu, X., Qu, C., Borella, C. P., Xie, H., Wilhelm, S. D., Leece, B. A., Bartle, L. M., Goldmacher, V. S., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm025540g · Cited by 116
Tumor Specific Novel Taxoid-Monoclonal Antibody Conjugates
Wu, X., & Ojima, I. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043455963 · Cited by 115
Toki, B. E., Cerveny, C. G., Wahl, A. F., & Senter, P. D. (2002) · The Journal of Organic Chemistry · doi:10.1021/jo016187+ · Cited by 96
Self-citationMadden, T. L., Tran, H. T., Beck, D., Huie, R., Newman, R. A., Pusztai, L., Wright, J. R., & Abbruzzese, J. L. (2000) · PubMed · Cited by 90
Clinical experience with edrecolomab: a monoclonal antibody therapy for colorectal carcinoma
Schwartzberg, L. S. (2001) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(01)00131-7 · Cited by 81
TZT‐1027, an Antimicrotubule Agent, Attacks Tumor Vasculature and Induces Tumor Cell Death
Otani, M., Natsume, T., Watanabe, J., Kobayashi, M., Murakoshi, M., Mikami, T., & Nakayama, T. (2000) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2000.tb01022.x · Cited by 76
Monoclonal Antibodies in the Treatment of Malignancy: Basic Concepts and Recent Developments
Dillman, R. O. (2001) · Cancer Investigation · doi:10.1081/cnv-100107745 · Cited by 67
Pettit, G. R. (1997) · Fortschritte der Chemie Organischer Naturstoffe/Fortschritte der Chemie organischer Naturstoffe/Progress in the chemistry of organic natural products · doi:10.1007/978-3-7091-6551-5_1 · Cited by 64
Rituximab: review and clinical applications focusing on non-Hodgkin’s lymphoma
King, K. M., & Younes, A. (2001) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.1.2.177 · Cited by 26
Cited by
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
Sun, T., Zhang, Y. S., Pang, B., Hyun, D. C., Yang, M., & Xia, Y. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201403036 · Cited by 2,164
Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index
Junutula, J. R., Raab, H., Clark, S., Bhakta, S., Leipold, D. D., Weir, S., Chen, Y., Simpson, M., Tsai, S. P., Dennis, M. S., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt.1480 · Cited by 1,382
Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomas
Younes, A., Bartlett, N. L., Leonard, J. P., Kennedy, D. A., Lynch, C. M., Sievers, E. L., & Forero-Torres, A. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002965 · Cited by 1,368
Effects of Drug Loading on the Antitumor Activity of a Monoclonal Antibody Drug Conjugate
Hamblett, K. J., Senter, P. D., Chace, D. F., Sun, M. M. C., Lenox, J., Cerveny, C. G., Kissler, K. M., Bernhardt, S. X., Kopcha, A. K., Zabinski, R. F., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0789 · Cited by 1,247
Self-citationNatural products to drugs: natural product-derived compounds in clinical trials
Butler, M. S. (2008) · Natural Product Reports · doi:10.1039/b514294f · Cited by 1,075
Metadata
- Authors
- Doronina, S. O., Toki, B. E., Torgov, M. Y., Mendelsohn, B. A., Cerveny, C. G., Chace, D. F., DeBlanc, R. L., Gearing, R. P., Bovee, T. D., Siegall, C. B., Francisco, J. A., Wahl, A. F., Meyer, D. L., & Senter, P. D.
- Venue
- Nature Biotechnology
- Published
- 2003-06-01
- Volume
- 21
- Issue
- 7
- Pages
- 778-784
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W2090057677
- Cited by
- 1,206
- References
- 29
- FWCI
- 11.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.